70% of M&A deals underperform.
Dr. Michelle Rozen is why yours won't.
Dr. Michelle Is Trusted By The World’s Leading Organizations
The Integration Is Running.
The People Aren't.
80%
78%
77%
The deal is closed. The work of making it real is just beginning.

Behavioral Science Is
Your Integration Advantage
Dr. Michelle Rozen — The Change Doctor™ — has spent over a decade researching exactly why people resist, disengage, and underperform during organizational change — and what leaders can do about it, using science.
Her frameworks (including The 0-10 Rule™ and The 6% Club methodology) give your leadership team a repeatable, evidence-based system for moving people through change — not around it.
Behavioral Science Is
Your Integration Advantage
Dr. Michelle Rozen — The Change Doctor™ — has spent over a decade researching exactly why people resist, disengage, and underperform during organizational change — and what leaders can do about it, using science.
Her frameworks (including The 0-10 Rule™ and The 6% Club methodology) give your leadership team a repeatable, evidence-based system for moving people through change — not around it.
Top Global Brands Trust Dr. Michelle Rozen


































































































































One team. One culture. One vision.
Workforce resistance you didn't anticipate
Culture clash forming faster than you can address it
Key talent signaling they're leaving
Leadership teams not aligned
Communication breaking down
Integration timelines slipping
M&A Challenges Have Met Their Match
The Deal Diagnostic
Before a single framework is deployed, Dr. Rozen reads the deal the way few leaders can, surfacing the cultural and executional hurdles that potentially erase billions in value. Dr. Rozen sees the failure before it happens, and prevents it with quick action.
30-minute diagnostic · No commitment required
The Custom Blueprint
Based on years of experience, Dr. Rozen architects the precise approach your unique culture and execution demand- the difference between an integration that compounds value and one that bleeds it.
The optimal Integration
At this phase, Dr. Rozen moves decisively, converting resistance into alignment and two organizations into one force. Talent stays. Momentum builds. The deal delivers the return the board was promised – one team, one culture, one vision.
A Glimpse into the Frameworks
The 0-10 Rule™
A behavioral framework that maps where every individual sits on the change adoption spectrum – from active resistance (0) to full commitment (10). Gives leaders the exact behavioral interventions to move people forward, not just push harder.
Applied in M&A:
Integration readiness diagnostics, leadership alignment scoring, targeted workforce communication strategy, and resistance mapping by team and function.
The Elite 6% Methodology
Based on peer-reviewed research showing that only 6% of people successfully execute long-term change – and why. The methodology identifies the behavioral patterns of that 6% and builds them into team-level practices that stick.
Applied in M&A:
Building manager change capability, sustaining culture integration post-close, reducing backsliding after Day 1, and identifying your internal change champions.
Need More?
Protect Your M&A Deal at Any Phase
Pre-Deal & Day 1
Leaders know the statistic. Over 60% of M&A deals fail to meet objectives.
Before close, they search for behavioral frameworks and advisors who can de-risk the human side before it’s too late.
Integration Phase
64% of managers assume resistance comes from front-line workers. Deloitte research shows it’s actually highest at top management level. When internal playbooks fail, they need a behavioral science perspective, fast.
Post-Close
Board accountability drives urgency. When key talent exits and synergy targets are missed, the CHRO and CEO face board-level scrutiny.
Budget is not the constraint at this stage – urgency is.
Start with a Change Readiness Assessment
- 30 minutes - no commitment required
- Covers resistance signals, leadership alignment, and culture friction
- You'll leave with a clear picture of your behavioral integration gaps
- All conversations are confidential
Meet Dr. Michelle Rozen
Dr. Michelle Rozen is a world-class behavioral scientist and one of the most sought-after M&A consultants on leadership, change, and integration acceleration today. Renowned for her decisive judgment, high-stakes composure, and deeply strategic approach, she transforms every merger into a high-performance outcome that drives measurable value. Her enterprise programs are fully customized to your deal, blending advanced behavioral science with practical, actionable frameworks that leaders implement immediately to achieve real business results.
Boards trust her for her incisive, precise, and unshakable style. Executives rely on her because she is seamless to work with, laser-focused on their objectives, and consistently delivers retained talent, protected value, and lasting impact. Engaging Dr. Michelle Rozen is more than hiring a consultant, it is securing a strategic, transformative partner who aligns, integrates, and accelerates your organization’s most critical deals.

Frequently Asked Questions
Is this a keynote engagement or a consulting engagement?
This page is specifically for organizations navigating M&A integration — not event bookings. If you’re looking for a keynote speaker for a conference or company event, visit the speaking page. The advisory work described on this page is a separate engagement led by Dr. Rozen and the Dr. Rozen Institute team.
At what point in the deal should we engage?
The earlier the better – ideally pre-close or in the first 30 days post-announcement. That said, many organizations come to us mid-integration when something has already gone wrong. We work at every stage, including recovery.
What size organizations do you work with?
Dr. Rozen has worked with organizations ranging from mid-market to Fortune 100. The frameworks are calibrated to deal complexity and workforce size, not a fixed engagement template.
What does the Change Readiness Assessment actually involve?
A 30-minute structured diagnostic conversation with Dr. Rozen or a senior team member. We cover the current state of the integration, specific resistance signals, leadership dynamics, and communication gaps. You’ll leave with a clear picture of where behavioral science can have the most impact – no commitment required.
What's the difference between this and a traditional change management firm?
Traditional change management is often process-focused – org charts, RACI matrices, project timelines. Dr. Rozen’s approach starts with the behavioral science of why people resist change at a neurological and psychological level, and builds interventions around that. The difference shows up in adoption rates, retention numbers, and leadership alignment speed.









